1039820-38-6 Usage
Classification
It belongs to the class of ethanolamines.
Function
It is a potent and selective small molecule inhibitor of the Bcl-2 family of proteins, which regulate cell survival and apoptosis.
Therapeutic applications
It has been extensively studied for its potential therapeutic applications in cancer treatment, specifically as a targeted therapy for Bcl-2-dependent malignancies.
Anticancer activity
It has shown promising anticancer activity in preclinical studies, making it a potential candidate for further drug development.
Role in immune responses and inflammation
It has also been investigated for its role in modulating immune responses and inflammation.
Potential impact
The chemical compound DFB-EtOH holds great promise for the development of novel cancer therapies and has the potential to significantly impact the field of oncology.
Check Digit Verification of cas no
The CAS Registry Mumber 1039820-38-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,9,8,2 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1039820-38:
(9*1)+(8*0)+(7*3)+(6*9)+(5*8)+(4*2)+(3*0)+(2*3)+(1*8)=146
146 % 10 = 6
So 1039820-38-6 is a valid CAS Registry Number.
1039820-38-6Relevant articles and documents
NITROIMIDAZOXADIAZOCINE COMPOUNDS
-
Page/Page column 57, (2013/06/05)
This invention relates to nitroimidazoxadiazocine compounds having the general Formula I, pharmaceutical compositions and uses of the same. The invention also relates to methods of making such nitroimidazoxadiazocine compounds of Formula I.
